I did touch on a little bit, but to expand, obviously, the growth plan for TruBridge is twofold. One, it's into the external market where we're continuing to see success. Obviously, the addition of HRG and the talent that we're seeing come in from a sales perspective and also just the scale and additional notoriety due to that deal, we're continuing to see additional momentum for TruBridge by itself. Bur over the next two or three years, our growth account for – or actually, the models that we have expects more growth from our installed customer base. So, there is a very close dependency between the success and the retention of our EHR customer base and the conversion of success for TruBridge. So, again, I think the number I shared in the prepared comments was $400 million, which is what's left from an opportunity standpoint for TruBridge inside the installed customer base, both acute and post-acute. And then, lastly, if you're thinking about the diamond in the rough, the Get Real Health, while it has some momentum in both the international and domestic market standalone, we also think that that is an opportunity, not just to help continue to satisfy our EHR customers, but also a wedge opportunity for us as we're bringing in RCM opportunities, and how we're positioning ourselves as the greater entity of CPSI. So, that's an area, obviously, that's a hot topic and a demand for most all facilities right now. And so, hopefully, that's something that we'll continue to leverage as an opportunity to bring our additional offerings, whether it's TruBridge or TruCode in behind Get Real Health.